
The NCAA asked the US Supreme Court to reinstate caps on athletic scholarships that were struck down last year, telling the justices that the association itself, not “one federal judge” engaged in “judicial meddling” and “micromanagement,” should “define the character” of college sports, reported Bloomberg Law.
The lower court rulings would “turn student-athletes into professionals, eradicating” the “decades-long hallmark of NCAA sports” and inviting “an endless string of antitrust lawsuits” while making “a single judge in California” the “superintendent” of eligibility, the conference stated in its Supreme Court petition. “This is not how antitrust law should work, and especially for the NCAA.”
The injunction invalidating the scholarship restrictions took effect in mid-August, after Justice Elena Kagan denied the association’s 11th hour bid for an emergency reprieve. The US Court of Appeals for the Ninth Circuit rejected a similar request a week earlier.
The Ninth Circuit in May upheld a California federal judge’s decision preserving the ban on outright pay for athletes but invalidating limits on education-related compensation.
In its petition asking the Supreme Court to review and reverse those decisions, the NCAA stated that they would upend the settled consensus that its amateurism standards are barely a matter of antitrust concern, let alone a violation.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Live Nation Under Criminal Antitrust Investigation Over Pandemic-Era Refund Policies
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas